| Literature DB >> 18924132 |
Frank Schmitz1, Antje Heit, Stefan Dreher, Katharina Eisenächer, Jörg Mages, Tobias Haas, Anne Krug, Klaus-Peter Janssen, Carsten J Kirschning, Hermann Wagner.
Abstract
The mammalian target of rapamycin (mTOR) can be viewed as cellular master complex scoring cellular vitality and stress. Whether mTOR controls also innate immune-defenses is currently unknown. Here we demonstrate that TLR activate mTOR via phosphoinositide 3-kinase/Akt. mTOR physically associates with the MyD88 scaffold protein to allow activation of interferon regulatory factor-5 and interferon regulatory factor-7, known as master transcription factors for pro-inflammatory cytokine- and type I IFN-genes. Unexpectedly, inactivation of mTOR did not prevent but increased lethality of endotoxin-mediated shock, which correlated with increased levels of IL-1beta. Mechanistically, mTOR suppresses caspase-1 activation, thus inhibits release of bioactive IL-1beta. We have identified mTOR as indispensable component of PRR signal pathways, which orchestrates the defense program of innate immune cells.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18924132 DOI: 10.1002/eji.200838761
Source DB: PubMed Journal: Eur J Immunol ISSN: 0014-2980 Impact factor: 5.532